Cardurion Pharmaceuticals website screenshot

Cardurion Pharmaceuticals

Cardurion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on transforming the treatment of cardiovascular disease and heart failure. Its research and development pipeline centers on novel small-molecule programs including PDE9 inhibition for chronic heart failure (HFrEF and HFpEF) and CaMKII inhibition for cardiac diseases such as catecholaminergic polymorphic ventricular tachycardia (CPVT). Cardurion combines target discovery, adaptive clinical trial design, and precision-medicine approaches, and was surfaced as a portfolio company of GV (Google Ventures). The company publishes a corporate and R&D website but does not expose a public developer API surface at this time.

Cardurion Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Pharmaceuticals, Biotechnology, and Cardiovascular.

Cardurion Pharmaceuticals’ developer surface includes engineering blog, support, and 5 more developer resources.

15.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesPharmaceuticalsBiotechnologyCardiovascularHeart FailureDrug DevelopmentClinical Trials

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 15.0/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cardurion-pharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: cardurion-pharmaceuticals
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/cardurion-pharmaceuticals.png
name: Cardurion Pharmaceuticals
description: Cardurion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on transforming the treatment
  of cardiovascular disease and heart failure. Its research and development pipeline centers on novel small-molecule programs
  including PDE9 inhibition for chronic heart failure (HFrEF and HFpEF) and CaMKII inhibition for cardiac diseases such as
  catecholaminergic polymorphic ventricular tachycardia (CPVT). Cardurion combines target discovery, adaptive clinical trial
  design, and precision-medicine approaches, and was surfaced as a portfolio company of GV (Google Ventures). The company
  publishes a corporate and R&D website but does not expose a public developer API surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/cardurion-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Pharmaceuticals
- Biotechnology
- Cardiovascular
- Heart Failure
- Drug Development
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/cardurion-pharmaceuticals-domain-security.yml
- type: Website
  url: https://cardurion.com
- type: About
  url: https://cardurion.com/about-cardurion/
- type: Blog
  url: https://cardurion.com/news/
- type: Support
  url: https://cardurion.com/#contact
- type: PrivacyPolicy
  url: https://cardurion.com/privacy-policy/
- type: TermsOfService
  url: https://cardurion.com/terms-of-use/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence